The clinical trial on tawa-tawa (Euphorbia hirta) as a potential adjunctive treatment for mild and moderate cases of coronavirus disease 2019 (COVID-19) is nearing completion, according to Dr. Philip Ian Padilla, vice chancellor for academic affairs of the University of the Philippines Visayas (UPV).
Padilla, a professor of Microbiology, is the principal investigator of the trial – a collaborative effort of UPV, Department of Science and Technology (DOST), Corazon Locsin Montelibano Memorial Regional Hospital in Bacolod City, Philippine Red Cross-Manila, and Quezon Institute.